A Study of Long-term Baricitinib (LY3009104) Therapy in Atopic Dermatitis
Clinical trial NCT03334435 · COMPLETED
Trial details
- NCT number
- NCT03334435
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-03-28
- Primary completion
- 2020-09-21
- Enrollment
- 1645
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.